Salesforce Buyback Program May Mitigate Investor Concerns Amid Growth Reacceleration Hopes Nvidia Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift Tracker Mortgages Gain Popularity Amid Uncertain Interest Rate Outlook Are They Right for You Love Factually Dating StartUps Promise to Cut the Cheats A New Market Niche Emerges South Korea Intensifies Oversight of Overseas Private Debt Investments Ebola Outbreak Forces DR Congo World Cup Squad into Extended Isolation Raising Logistics and Cost Concerns Tower Semiconductor Ltd TSEM Q1 2026 Earnings Robust EPS Beat Highlights Operational Discipline Amid Revenue Uncertainty Mereo BioPharma Group plc MREO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uplift AGNCZ Q1 2026 Earnings EPS Surpasses Estimates with 145 Beat Preferred Shares Edge Higher PAGP Q1 2026 Earnings Strong EPS Surprise of 11972 Beats Estimates CVV Q1 2026 Earnings Narrowing Losses as Operational Efficiencies Begin to Emerge OTTR Q1 2026 Earnings Earnings Beat Estimates as EPS Surges 1986 Above Consensus NCDL Slips Slightly as Shares Trade in Established Range Mega Matrix Inc MPU Plunges 21 Approaches Key Support at 040 Iron Horse Acquisitions II Corp IRHOU Holds Steady at 1017 Amid Quiet Trading Birkenstock BIRK Surges 46 Rebounds from Support Eyes Resistance Ameriprise Financial AMP Edges Higher as Support Holds Resistance Ahead Modal Labs Secures 465 Billion Valuation in Rapidly Expanding AI Coding Market PNR Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher KE Holdings BEKE Edges Higher as Stock Holds Near Support VNET Q4 2025 Earnings Record EPS Beat on Surprise Profitability AMTD IDEA Group Q4 2020 Earnings Strong EPS Beat Amid Revenue Disclosure Gap RBRK Q1 2026 Earnings Surprise Profit Beats Expectations as Cost Discipline Drives Results BN Q1 2026 Earnings Slight EPS Beat Amid Resilient Asset Management Performance ELBM Q4 2025 Earnings Deep EPS Miss Amid Strategic Progress Stock Gains Slightly Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress BOC Q4 2025 Earnings Deep Loss Misses Estimate Despite Stock Rebound